Evoke Wealth, LLC Reata Pharmaceuticals Inc Transaction History

Evoke Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$102.03 - $184.62 $1,122 - $2,030	-11 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$93.53 - $163.34 $1,028 - $1,796	11 New	11 $1,000
Q2 2020 Aug 10, 2020	SELL	$126.3 - $176.56 $5,430 - $7,592	-43 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$124.16 - $247.74 $1,862 - $3,716	-15 Reduced 25.86%	43 $6.21 Million
Q3 2019 Nov 12, 2019	BUY	$71.26 - $95.75 $4,133 - $5,553	58 New	58 $4.66 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.